Olden K, Pratt R M, Yamada K M
Cell. 1978 Mar;13(3):461-73. doi: 10.1016/0092-8674(78)90320-3.
Using tunicamycin, we have investigated the role of glycosylation in the biosynthesis, processing and turnover of CSP, the major cell surface glycoprotein of chick embryo fibroblasts (CEF). This antibiotic specifically inhibits glycosylation mediated by dolichol pyrophosphate and consequently inhibits the glycosylation of asparaginyl residues of glycoproteins. Tunicamycin inhibited the incorporation of 3H-mannose into CSP by 92--98% and 14C-glucosamine by 84--96%, whereas total protein synthesis was decreased by only 15--45%. Tunicamycin treatment decreased total amounts of CSP by approximately 50--65%, with equal decreases in CSP occurring on the cell surface and in culture medium, whereas intracellular pools of CSP were not substantially affected. In contrast to CSP, three other membrane-associated proteins of apparent molecular weights 75,000, 95,000 and 150,000 daltons were found in increased amounts. Procollagen secretion was not inhibited by tunicamycin. Both procollagen and CSP secretion into culture medium were also not increased in AD6, a glycosylation-deficient, mutant mouse 3T3 cell line compared to wild-type cells. We examined the mechanism of the decrease in CSP after tunicamycin treatment. The rate of CSP biosynthesis as measured by pulse-labeling with 14C-leucine was not altered. Tunicamycin had only a slight effect on the initial times and rates of CSP appearance on the cell surface; some apparent intracellular redistribution of CSP was detected by immunofluorescence. The major effect of tunicamycin treatment was to accelerate the rate of degradation of CSP 2--3 fold. This increase is sufficient to account for the observed decreases after tunicamycin treatment. Our results suggest that carbohydrates may not be essential for CSP or procollagen synthesis, intracellular processing and secretion, but that carbohydrates may help stabilize CSP against proteolytic degradation.
我们使用衣霉素研究了糖基化在鸡胚成纤维细胞(CEF)主要细胞表面糖蛋白CSP的生物合成、加工和周转中的作用。这种抗生素特异性抑制由焦磷酸多萜醇介导的糖基化,从而抑制糖蛋白中天冬酰胺残基的糖基化。衣霉素使3H-甘露糖掺入CSP的量减少了92% - 98%,使14C-葡糖胺掺入量减少了84% - 96%,而总蛋白质合成仅减少了15% - 45%。衣霉素处理使CSP总量减少了约50% - 65%,细胞表面和培养基中的CSP减少量相等,而细胞内CSP池未受到实质性影响。与CSP相反,另外三种表观分子量分别为75,000、95,000和150,000道尔顿的膜相关蛋白的量增加。前胶原的分泌不受衣霉素抑制。与野生型细胞相比,在糖基化缺陷的突变小鼠3T3细胞系AD6中,前胶原和CSP分泌到培养基中的量也没有增加。我们研究了衣霉素处理后CSP减少的机制。用14C-亮氨酸脉冲标记法测定的CSP生物合成速率没有改变。衣霉素对CSP出现在细胞表面的初始时间和速率只有轻微影响;通过免疫荧光检测到CSP在细胞内有一些明显的重新分布。衣霉素处理的主要作用是使CSP的降解速率加快2 - 3倍。这种增加足以解释衣霉素处理后观察到的减少。我们的结果表明,碳水化合物对于CSP或前胶原的合成、细胞内加工和分泌可能不是必需的,但碳水化合物可能有助于稳定CSP以抵抗蛋白水解降解。